Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-29 @ 9:19 PM
Study NCT ID:
NCT01772368
Status:
COMPLETED
Last Update Posted:
2017-06-12
First Post:
2013-01-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-17
First Submit QC Date:
None
Study First Post Date:
2013-01-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-28
Results First Submit QC Date:
None
Results First Post Date:
2017-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-04-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-05-10
Last Update Post Date:
2017-06-12
Last Update Post Date Type:
ACTUAL